Literature DB >> 25275905

LOXL1-associated candidate epithelial pathomechanisms in exfoliation glaucoma.

Rozalia Laczko1, Kornelia M Szauter, Katalin Csiszar.   

Abstract

Results of the present study support ocular epithelia-specific LOXL1 functions in exfoliation glaucoma that may include both dysregulated extracellular matrix cross-linking activity and cellular mechanisms involving a role for LOXL1, in direct interaction with Snail1, in promoting epithelial to mesenchymal transition and a potential shift towards fibrogenic epithelial cell phenotypes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25275905      PMCID: PMC4205763          DOI: 10.1097/IJG.0000000000000105

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  24 in total

1.  Lysyl oxidase-like protein from bovine aorta. Isolation and maturation to an active form by bone morphogenetic protein-1.

Authors:  A Borel; D Eichenberger; J Farjanel; E Kessler; C Gleyzal; D J Hulmes; P Sommer; B Font
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

2.  Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.

Authors:  Matthias Zenkel; Anita Krysta; Francesca Pasutto; Anselm Juenemann; Friedrich E Kruse; Ursula Schlötzer-Schrehardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

3.  A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.

Authors:  Héctor Peinado; Maria Del Carmen Iglesias-de la Cruz; David Olmeda; Katalin Csiszar; Keith S K Fong; Sonia Vega; Maria Angela Nieto; Amparo Cano; Francisco Portillo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

Review 4.  Molecular genetics in glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2011-08-18       Impact factor: 3.467

5.  Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: changes in the expression of LOXL during development and growth of mouse tissues.

Authors:  Kimiko Hayashi; Keith S K Fong; Frederic Mercier; Charles D Boyd; Katalin Csiszar; Masando Hayashi
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

6.  Transforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells.

Authors:  Anirudh Sethi; Weiming Mao; Robert J Wordinger; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-15       Impact factor: 4.799

7.  Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives.

Authors:  Boris Hinz; Giulio Gabbiani
Journal:  F1000 Biol Rep       Date:  2010-11-11

8.  Epithelial mesenchymal transition-like phenomenon in trabecular meshwork cells.

Authors:  Eri Takahashi; Toshihiro Inoue; Tomokazu Fujimoto; Sachi Kojima; Hidenobu Tanihara
Journal:  Exp Eye Res       Date:  2013-11-27       Impact factor: 3.467

9.  High glucose induced differential expression of lysyl oxidase and its isoform in ARPE-19 cells.

Authors:  Karunakaran Coral; Jagadeesan Madhavan; Rishi Pukhraj; Narayanasamy Angayarkanni
Journal:  Curr Eye Res       Date:  2012-09-11       Impact factor: 2.424

10.  Genetics and genomics of pseudoexfoliation syndrome/glaucoma.

Authors:  Ursula Schlötzer-Schrehardt
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01
View more
  2 in total

1.  Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses.

Authors:  Jie Zhao; Abby Adams; Steven A Weinman; Irina Tikhanovich
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

2.  Cleavage of LOXL1 by BMP1 and ADAMTS14 Proteases Suggests a Role for Proteolytic Processing in the Regulation of LOXL1 Function.

Authors:  Tamara Rosell-García; Sergio Rivas-Muñoz; Alain Colige; Fernando Rodriguez-Pascual
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.